The prevalence of Parkinson's disease in an Arab population, Wadi Ara, Israel

Israel Medical Association Journal

Volumn 12, Issue 1, 2010, Pages 32-35

  Masalha, Rafik ^a   Kordysh, Ella ^b   Alpert, Gershon ^c   Hallak, Maher ^b   Morad, Mohammad ^c   Mahajnah, Muhammad ^d   Farkas, Peter ^a   Herishanu, Yuval ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Arab population; Drug tracer approach; Parkinson's disease; Prevalence; Wadi Ara

Indexed keywords

AMANTADINE SULFATE; ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; PERGOLIDE; ROPINIROLE; SELEGILINE;

ADOLESCENT; ADULT; AGED; AGRICULTURE; ARAB; ARTICLE; CIGARETTE SMOKING; CITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; ISRAEL; MALE; PARKINSON DISEASE; PREVALENCE; RURAL AREA; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARABS; CATCHMENT AREA (HEALTH); FEMALE; HUMANS; ISLAM; ISRAEL; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 76049111772     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wang Y. The incidence and prevalence of Parkinson's disease in the People's Republic of China. Chung-Hua Liu Hsing Ping Hsueh Tsa Chih (Chinese J Epidemiol) 1991; 12: 363-5.
2. Melcon MO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinsoǹs disease in Junin, Buenos Aires Province, Argentina. Mov Disord 1997; 12: 197-205.
3. Benamer HTS, de Silva R, Siddiqui KA, Grosset DG. Parkinson Disease in Arabs: a systematic review. Mov Disord 2008; 9: 1205-10.
4. Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinsoǹs disease in Benghazi, North-East Libya. Clin Neurol Neurosurg 1986; 88: 109-13.
5. Al Rajeh S, Bademosi O, Ismail H, et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 1993; 12: 164-78.
6. Attia Romdhane N, Ben Hamida M, Mrabet A, et al. Prevalence study of neurologic disorders in Kelibia (Tunisia). Neuroepidemiology 1993; 12: 285-99.
7. Lai BCL, Schulzer M, Marion S, Teschke K, Tsui JK. The prevalence of Parkinsoǹs disease in British Columbia, Canada, estimated by using drug tracer methodology. Parkinsonism Relat Disord 2003; 9: 233-8.
8. Nisipeanu P, Inzelberg E, Abo Mouch S, et al. Parkin gene causing benign autosomal recessive juvenile parkinsonism. Neurology 2001; 56: 1573-5.
9. De Pedro-Cuesta J. Parkinsoǹs disease occurrence in Europe. Acta Neurol Scand 1991; 84: 357-65.
10. de Rijk MC, Tzouri C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 10-15.
11. Herishanu YO, Goldsmith JR, Abarbanel 11. JM, Weinbaum Z. Clustering of Parkinsoǹs disease in southern Israel. Can J Neurol Sci 1989; 16: 402-5.
12. HYPERLINK "http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&C md=ShowDetailView&TermToSearch=9604134&ordinalpos=9&itool=Ent rezSystem2.PEntrez.Pubmed.Pubmed-ResultsPanel.Pubmed-RVDocSum" Herishanu YO, Kordysh E, Goldsmith JR. A case-referent study of extrapyramidal signs (preparkinsonism) in rural communities of Israel. Can J Neurol Sci 1998; 25(2): 127-33.
13. Anca M, Paleacu D, Shabtai H, Giladi N. Cross-sectional study of the prevalence of Parkinson disease in the kibbutz movement in Israel. Neuroepidemiology 2002; 21: 50-5.
14. Von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473-90.
15. De Pedro-Cuesta J, Petersen IJ, Vassilopoulos D, Michelli F, Garcia-Inesta A. Epidemiological assessment of levodopa use by populations. Acta Neurol Scand 1991; 83: 328-35.
16. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door to door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 1992; 42: 1901-7.
17. De Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995; 45: 2142-6.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease, a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 275-8.
19. Mayeux R, Denaro J, Hemengildo N, Marder K, Tang MX, Cote LJ. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992; 149: 49-57.
20. Bronstein J, Carvey P, Chen H, et al. Meeting Report: Consensus Statement - Parkinson's Disease and the Environment: Collaborative on Health and the Environment and Parkinson's Action Network (CHE PAN) Conference 26-28 June 2007. Environ Health Perspect 2009; 117: 117-21.
21. Zhang ZX, Roman GC. Worldwide occurrence of Parkinsoǹs disease: an updated review. Neuroepidemiology 1993; 12: 195-208.
22. Gorell JM, Johnson CC, Rybicki BA Peterson EL, Richardson RJ. The risk of Parkinsoǹs disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50: 1346-50.
23. Tuchsen F, Jensen AA. Agricultural work and the risk of Parkinsoǹs disease in Denmark, 1981-1993. Scand J Work Environ Health 2000; 26: 359-62.
24. Dick FD, De Palma G, Ahmadi A, et al. Environmental risk factors in Parkinsoǹs disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2007; 64: 666-72.
25. Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinsoǹs disease. Arch Neurol 2007; 64: 990-7.